|
.
|
|
Sunday, March 7, 2004 — 8:30 AM — Room 1 |
The Spectrum of Fibroblastic Tumors: Current Insights
|
|
Moderator: |
John Hicks, Texas Children's
Hospital, Baylor College of Medicine, Houston, TX |
|
8:30 |
Phenotypic Plasticity of the Fibroblast: Basis for Understanding and Diagnosing Fibroblastic Tumors- Brian Eyden, Christie Hospital NHS Trust, Manchester, UK [Handout: HTML, PDF] |
|
9:15 |
Low Grade Sarcoma with CD34 Positive Fibroblasts, and Low Grade Myofibroblastic Sarcomas- Cyril Fisher, Royal Marsden Hospital,
London, UK [Handout: HTML, PDF] |
|
10:00 |
Break |
|
10:30 |
A Survey of Fibrosarcomas: Extending from Low Grade Fibromyxoid Sarcoma to Adult Fibrosarcoma- Cristina E. Antonescu, Memorial
Sloan Kettering Cancer Center, New York, NY [Handout: HTML, PDF] |
|
11:05 |
The Rise and Fall of Malignant Fibrous Histiocytoma- Robert A. Erlandson, Memorial Sloan-Kettering Cancer Center, South
Burlington, VT |
|
11:40 |
Pediatric Fibroblastic and Myofibroblastic Tumors: What's New and What's Not - John Hicks, Texas Children's Hospital, Baylor
College of Medicine, Houston, TX [Handout: HTML, PDF] | |